
Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications
Author(s) -
Veerendra Sandur,
M. Murugesh,
Vaibhav S Banait,
Pravin Rathi,
Shobna Bhatia,
J. M. Joshi,
Arvind Kate
Publication year - 2014
Publication title -
journal of postgraduate medicine/journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.138754
Subject(s) - medicine , asthma , gerd , omeprazole , reflux , proton pump inhibitor , pulmonary function testing , gastroenterology , disease
The hypothesis that GER can trigger or exacerbate asthma is supported by several clinical trials that have shown amelioration in asthma symptoms and/or an improvement in pulmonary function after antireflux therapy.